After 13 years at the helm, including last year’s merger with the University of Pennsylvania Health System, Doylestown Health CEO Jim Brexler is retiring April 30, writes John George for the Philadelphia Business Journal.
By joining Penn Medicine, the independent Doylestown Health gained the financial support and capital backing needed to sustain its level of clinical excellence. The increased scale also expands the number of specialists and services, benefiting patients.
“If for some reason we run into an issue in some service line, we immediately can work within the system to bring somebody else in — and we’re not recruiting as a stand-alone community hospital,” said Brexler.
As far as the future of health care delivery in the region is concerned, Brexler is optimistic.
“I think the challenge is surviving through this very awkward period we’re in right now where there is a mismatch between the revenue streams and the costs,” he said.
Solving that issue involves simplifying how patients and their families access care and information so they can return home more easily, with an emphasis on reducing complexity and maintaining a patient-centered approach.
Read more about Doylestown Health CEO Jim Brexler’s retirement and his outlook on the healthcare industry in the Philadelphia Business Journal.
_______
